Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$944M |
| 2 |
Amazon
AMZN
|
+$935M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$517M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$341M |
| 5 |
Netflix
NFLX
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.29B |
| 2 |
NVIDIA
NVDA
|
+$588M |
| 3 |
Bank of America
BAC
|
+$289M |
| 4 |
Intel
INTC
|
+$288M |
| 5 |
Union Pacific
UNP
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.77% |
| 2 | Technology | 1.83% |
| 3 | Communication Services | 1.58% |
| 4 | Consumer Discretionary | 1.42% |
| 5 | Healthcare | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
CALL
Ligand Pharmaceuticals
LGND
$5.59B
| $1.09M | ﹤0.01% |
10,580
+3,206
| +43% | +$317K |
|
5027
PUT
Stepan Co
SCL
$1.42B
| $1.09M | ﹤0.01% |
13,100
-18,600
| -59% | -$1.47M |
|
5028
Thermo Fisher Scientific
TMO
$230B
| $1.09M | ﹤0.01% |
5,281
-45,012
| -89% | -$9.45M |
|
5029
PUT
Open Text
OTEX
$6.08B
| $1.09M | ﹤0.01% |
31,300
+22,500
| +256% | +$785K |
|
5030
Patterson-UTI
PTEN
$4.74B
| $1.09M | ﹤0.01% |
62,124
-78,555
| -56% | -$1.64M |
|
|
NETI
5031
PUT
DELISTED
Eneti Inc.
NETI
| $1.09M | ﹤0.01% |
16,592
+7,704
| +87% | +$552K |
|
5032
PUT
Sally Beauty Holdings
SBH
$1.55B
| $1.09M | ﹤0.01% |
66,000
+31,700
| +92% | +$544K |
|
5033
iShares Global Materials ETF
MXI
$377M
| $1.08M | ﹤0.01% |
16,060
+10,864
| +209% | +$770K |
|
|
BFYT
5034
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.08M | ﹤0.01% |
37,529
+18,208
| +94% | +$511K |
|
5035
PUT
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.49B
| $1.08M | ﹤0.01% |
14,700
+500
| +4% | +$36.9K |
|
5036
Marathon Petroleum
MPC
$104B
| $1.08M | ﹤0.01% |
14,800
-157,400
| -91% | -$10.8M |
|
|
HCRF
5037
DELISTED
iShares Edge MSCI Multifactor Healthcare ETF
HCRF
| $1.08M | ﹤0.01% |
34,647
+14,868
| +75% | +$487K |
|
|
SHOE
5038
PUT
Shoe Station Group
SHOE
$372M
| $1.08M | ﹤0.01% |
+90,800
| New | +$1.09M |
|
|
TRVG
5039
PUT
trivago
TRVG
$423M
| $1.08M | ﹤0.01% |
31,100
-132,840
| -81% | -$5.23M |
|
|
AVP
5040
PUT
DELISTED
Avon Products, Inc.
AVP
| $1.08M | ﹤0.01% |
380,500
+97,400
| +34% | +$246K |
|
5041
PUT
HCI Group
HCI
$2.32B
| $1.08M | ﹤0.01% |
28,300
-81,400
| -74% | -$2.94M |
|
5042
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$74.6M
| $1.08M | ﹤0.01% |
16,330
+4,195
| +35% | +$294K |
|
5043
Preferred Bank
PFBC
$1.23B
| $1.08M | ﹤0.01% |
16,773
-9,112
| -35% | -$581K |
|
5044
PUT
iShares MSCI Thailand ETF
THD
$351M
| $1.08M | ﹤0.01% |
10,800
+7,400
| +218% | +$730K |
|
|
SRNE
5045
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.08M | ﹤0.01% |
+209,100
| New | +$1.49M |
|
5046
Neurogene
NGNE
$732M
| $1.08M | ﹤0.01% |
3,822
+1,739
| +83% | +$480K |
|
5047
PUT
Belden
BDC
$4.5B
| $1.07M | ﹤0.01% |
15,600
-7,600
| -33% | -$584K |
|
5048
CALL
ALPS Medical Breakthroughs ETF
SBIO
$228M
| $1.07M | ﹤0.01% |
31,400
+13,200
| +73% | +$463K |
|
5049
Seaboard Corp
SEB
$3.75B
| $1.07M | ﹤0.01% |
252
-405
| -62% | -$1.69M |
|
|
CALD
5050
CALL
DELISTED
Callidus Software, Inc.
CALD
| $1.07M | ﹤0.01% |
29,900
+22,400
| +299% | +$765K |
|
Similar funds
Jeff Yass's Q1 2018 Portfolio in Review
As of Q1 2018, Jeff Yass held 10,979 positions worth $281B, down 1% from $283B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q1 2018 filing shows 1,821 new, 3,804 increased, 3,502 reduced and 1,753 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M. The largest sale was Apple, an estimated $1.29B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q1 2018 buy was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q1 2018, an estimated $944M increase.
- Jeff Yass's biggest Q1 2018 reduction was Apple, cutting an estimated $1.29B.
- Jeff Yass fully exited iShares MSCI Japan ETF in Q1 2018, selling an estimated $84.1M.
- Jeff Yass's ten largest holdings make up 27% of its $281B portfolio in Q1 2018.
- Jeff Yass opened 1,821 new positions and closed 1,753 in Q1 2018.
- Jeff Yass's portfolio value fell 1% quarter-over-quarter to $281B.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.